Company Filing History:
Years Active: 2009-2011
Title: Belinda Abbott: Innovator in Anti-Thrombotic Therapy
Introduction
Belinda Abbott is a prominent inventor based in Burwood, Australia. She has made significant contributions to the field of medical research, particularly in the development of anti-thrombotic therapies. With a total of two patents to her name, Abbott's work is paving the way for innovative treatments in this critical area of healthcare.
Latest Patents
Abbott's latest patents focus on the inhibition of phosphoinositide 3-kinase β. The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase β, which are used in anti-thrombotic therapy. Additionally, her work includes a method for screening compounds that are useful for new anti-thrombotic therapies by detecting the selective inhibitory activity of PI 3-kinase β of the compound. The invention also encompasses novel compounds that act as inhibitors of PI 3-kinase.
Career Highlights
Belinda Abbott is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca allows her to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Abbott has worked alongside notable colleagues such as Shaun P. Jackson and Alan Duncan Robertson. These collaborations have further enhanced her research and innovation in the medical field.
Conclusion
Belinda Abbott's contributions to the field of anti-thrombotic therapy through her innovative patents and collaborations highlight her as a key figure in medical research. Her work continues to inspire advancements in healthcare solutions.